Investors / United States / Emergent Medical Partners
Emergent Medical Partners
Venture capital · San Jose, CA, United States · North America
Emergent Medical Partners is an investment firm focused on medical devices and the life sciences. It supports early-stage life science entrepreneurs with guidance through the clinical, operational, legal, financial and regulatory challenges of medical device development.
Invests inHealthcare & Biotech
In its own wordsmedical deviceslife scienceshealthcareearly stage
Your fit with Emergent Medical Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsEmergent Medical Partners lists 16 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (81%), Industrial & Manufacturing (13%) and Space & Defense (6%). 70% of its companies are based in United States. It invests most often alongside Lightstone Ventures, U.S. Venture Partners and Aera VC.
No funding round on record names Emergent Medical Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not Emergent Medical Partners' whole history. Rounds on record name 0 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 42th | 16 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 93th | 81% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1063%
- No longer answers00%
- Points to another company638%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 81% | 15% |
| Industrial & Manufacturing | 13% | 7% |
| Space & Defense | 6% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Lightstone Ventures
Compare Emergent Medical Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The Arterys platform extracts actionable insights from medical images to add clinical value, improve diagnostic decision making, efficiency and productivity. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
Healthcare & Biotech | Portfolio page | |||
Healthcare & Biotech | Portfolio page | |||
| EBR Systems develops and manufactures a leadless left ventricular endocardial pacing device for heart failure treatment. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Fractyl Health pursues therapies that target root causes of obesity and type 2 diabetes | Healthcare & Biotech | Portfolio page | ||
| Heartflow creates a detailed 3D model of the heart using AI analysis to help personalize treatment journeys for patients with coronary artery disease. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Orlucent has developed a handheld fluorescent molecular imaging system to non-invasively evaluate early tissue remodeling that signals the likelihood of a mole's transition to melanoma. | Healthcare & Biotech | Portfolio page | ||
Industrial & Manufacturing | Portfolio page | |||
Healthcare & Biotech | Portfolio page | |||
| Shape Memory Medical develops and manufactures medical devices using smart polymer technology for peripheral and neurovascular solutions. | Healthcare & Biotech | Portfolio page | ||
| Standard Bariatrics produces medical devices, such as staplers, for bariatric surgery procedures. | Healthcare & Biotech | Portfolio page | ||
| Suture Ease develops and sells medical suturing devices and systems | Healthcare & Biotech | Portfolio page | ||
| Twelve is a next-generation industrial company that advances how everyday products are made from the molecule up using its Power-to-X hydrocarbon platform. | Industrial & ManufacturingSpace & Defense | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- emvllp.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Emergent Medical Partners' profile as data
Pull Emergent Medical Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/emvllp.com
# also
GET /v1/firms/emvllp.com/portfolio
GET /v1/firms/emvllp.com/coinvestors
GET /v1/firms/emvllp.com/news